Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...

The crystal structure of the hemagglutinin of both the viruses is similar, especially within the Sa antigenic site. Compared with seasonal influenza ... cross-reactive antibodies developed through ...

Infectimune® studies funded by and performed by investigators at the National Institute of Allergy and Infectious Diseases (NIAID)’s Center for Influenza Vaccine Research for High-Risk Populations ...

The first research programs attempting to develop an inactivated influenza ... two-digit year for viruses isolated during the 1900s); The subtype [16 possible hemagglutinin and 9 possible ...

These proteins are what allows a virus to attach to "healthy" cells and start the process of infection. Current influenza ...

While current influenza vaccines primarily target the variable hemagglutinin protein, the slower-evolving neuraminidase presents a promising target for the development of new vaccines providing ...

From egg prices to pet food recalls – and now, confirmation that another strain of bird flu has infected a large commercial ...

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...